|Definition||Viral hepatitis is a dangerous infectious liver disease which includes several types depending on the type of virus. Of all forms of viral hepatitis, hepatitis A is the most common.|
|Specialty||Virology and hepatology|
|History||In 1950-1983, registration and characterization of outbreaks of hepatitis of unknown etiology in Southeast Asia occurred. The first description of the outbreak and the actual data obtained during its decoding allowed Mohammed Sultan Khuroo et al. suggest that it is associated with a virus unknown to science. In 1992, molecular characterization of HEV isolates was obtained in various regions of the world. The development and implementation of PCR for the detection of HEV, as well as sequencing methods, made it possible to determine the level of spread of the virus.|
|Symptoms||At first, before the onset of jaundice, hepatitis resembles the flu and begins with fever, headache, general malaise, body aches, as in hepatitis A. In hepatitis B and C, the onset is usually more gradual, without a sharp rise in temperature. Initial manifestations of hepatitis C may be limited to weakness and loss of appetite. After a few days, the picture begins to change: appetite disappears, pains appear in the right hypochondria, nausea, vomiting, urine darkens, and feces become discolored.|
|Causes||Acute viral hepatitis can be caused by different types of viruses. These include: hepatitis A, B, C, E, D, and other viruses.|
|Virology||Hepatitis viruses enter the human body in two main ways. A sick person can excrete the virus with feces, after which it enters the intestines of other people with water or food. It is characteristic of hepatitis A and E viruses. The second route of infection is human contact with infected blood. It is characteristic of hepatitis B, C, D, G viruses.|
|Prevention||To protect oneself from infection with hepatitis, one should not use unboiled water, always wash fruits and vegetables, do not neglect the heat treatment of food. This can help prevent hepatitis A infection. In general, contact with other people’s body fluids should be avoided, especially with blood.|
|Diagnostic Method||In most cases, viral hepatitis proceeds subclinically and is diagnosed only on the basis of additional studies, including laboratory data. An increase in ALT, AST, the level of Bilirubin more than 10 times normal is a reliable test for acute hepatitis.|
|Treatment||There are no specific methods of treatment, therefore, the majority of patients undergo basic treatment. Hospitalization is necessary only in case of a severe course of the disease and in the absence of the possibility of providing a regimen at home. Patient care should include measures to prevent the transmission of infection. A strict diet is not required, but the patient needs to exclude fats from the diet and consume more juices. Persons who have had acute hepatitis are shown to refrain from taking alcohol until the liver function is completely normalized.|
|Duration||Complete recovery from acute hepatitis usually occurs within a few weeks, rarely months. Fatigue and lack of appetite often persist in most patients for a long period.|
|Prognosis||Acute viral hepatitis B, C and D often become chronic. Acute hepatitis is sometimes characterized by a relapsing course. The most unfavorable outcome of acute hepatitis is chronic disease.|
|Complications||Functional and inflammatory diseases of the biliary tract and hepatic coma can become complications of viral hepatitis, and if a violation in the work of the biliary tract can be treated, then hepatic coma is a formidable sign of a fulminant form of hepatitis, ending in death in almost 90% of cases. In 80% of cases, the fulminant course is due to the combined action of hepatitis B and D viruses.|
|Frequency in Population||More than 2 billion people today have serological evidence of past or present hepatitis infection. 250 million are chronically infected and at risk development of liver disease associated with hepatitis.|
|Deaths||Number of deaths from hepatitis-related liver diseases estimated at 786,000 annually.|
|Society||There are still many stereotypes about hepatitis: that it is a deadly disease that is transmitted only through promiscuity and drug use. These misconceptions are common not only in society, but also among the patients themselves: only one in six people with hepatitis feels sufficiently informed about their disease.|
Hepatitis Research Papers Examples
In order to assess the potential threat of infectious ailments in Miami, three illnesses can be taken as a basis – hepatitis B, influenza, and syphilis.
This paper presents epidemiological and surveillance data related to rabies, AIDS, and hepatitis B in Miami, Florida.
Best Hepatitis Essay Titles
- Autochthonous and Travel Acquired Hepatitis E Virus in Australia
- The 5BSL3.2 Functional Rna Domain Connects Distant Regions in the Hepatitis C Virus Genome
- Sexually Transmitted Hepatitis Prevention and Treatment
- Hepatitis Virus Causes and Treatments by Interferon Biology
- Circulating MicroRNAs: Promising Candidates Serving as Novel Biomarkers of Acute Hepatitis
- Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
- Antibody Level After Hepatitis B Vaccination in Hemodialysis
- Genetic Modified Potatoes Vaccines Based for Hepatitis B
- Prolyl Isomerase pin1 Regulates the Stability of Hepatitis B Virus Core, Protein
- Molecular Biology and Infection of Hepatitis E Virus
- Health Promotion Intervention Plan: Hepatitis B
- Chronic Hepatitis C-related Cirrhosis Hospitalization Cost Analysis in Bulgaria
- Autoimmune Hepatitis Global Clinical Trials Review 2015
- The Correlation Between Hepatitis B Virus Precore & Core Mutations and the Progression of Severe Liver Disease
- The Complement System and c1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia
- Vaccine Development Against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges
- Hepatitis: Vaccination and Organic Antioxidant Blend
- Acute Motor Axonal Neuropathy in Association With Hepatitis E
- Blood Borne and Infectious Diseases: Hepatitis C
- Acquired Hepatitis During Surgery
- Research Into the Hepatitis B Virus
- The Willowbrook Hepatitis Experiments by Dr. Saul Krugman
- Drugs Use and Abuse: Needle Sharing, HIV and Hepatitis
- Host Cell Rab GTPases in Hepatitis B Virus Infection
- The Autoimmune Hepatitis Is Liver Disease Which Characterized by Impaired Immunity
- Novel Immunotherapies for Autoimmune Hepatitis
- The Case for Increased Testing for Chronic Hepatitis B Virus by the CDC
- Antibody Titers Following Hepatitis B Vaccination in Health Care Workers in Khartoum State, Sudan
- The Swiss Hepatitis Strategy as a Model for Facing Future Health Policy Challenges
- Transfused Blood, Serum Hepatitis, and the Coase Theorem
- Live Attenuated Vaccine Based on Duck Enteritis Virus Against Duck Hepatitis a Virus Types 1 and 3
- Transmission, Diagnosis, and Treatment of Hepatitis B
- The Stigma Associated With the Hepatitis C Virus
- Hepatitis A,B,C,D,E,G: History, Symptoms, Causes, Treatment
- Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis
- Hla Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance
- Canada and the Prevalence of Hepatitis C
- Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-line Treatment of Hepatitis B Virus in Italy
- Understanding the Silent Killer, the Hepatitis C Virus
- Advanced Glycation End Products as a Predictor of Diabetes Mellitus in Chronic Hepatitis C-related Cirrhosis
❓ Hepatitis Research Questions
- What Does Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies Mean?
- What Matters Most for Treatment Decisions in Hepatitis C: Effectiveness, Costs, and Altruism?
- What Are the Most Common Causes and Consequences of Hepatitis?
- How Should the Epidemiology of Acute Hepatitis C and Opioid Use Affect Health Policy Decision-making?
- What Are the Causes and Effects of Hepatitis B, Schistosomiasis, and Malaria?
- What Is the Most Important Thing for Patients With Hepatitis C To Know?
- What Are the Treatment Methods for Patients Diagnosed With Hepatitis C Virus?
- What Is Immunoglobulin Hepatitis Hav?
- Why Do Cameroon Medicinal Plant Extracts Strongly Inhibit Hepatitis C Virus Infection in Vitro?
- How Does Chronic Viral Hepatitis of the Liver Develop?
- What Are the Symptoms of Chronic Hepatitis?
- What Are the Dry Spot Tests for the Diagnosis and Therapeutic Monitoring of Viral Hepatitis B and C?
- How Does Grape Seed Extract Attenuate HCV Replication and Viral-induced Inflammation?
- What Are the Causes, Diagnosis, and Treatment of Hepatitis B?
- Alcoholic Hepatitis and Liver Transplantation: The Good News and What To Do About It?
- What Is Serum Hepatitis and How Does It Affect the Body?
- Natural Killer Cell Functional Dichotomy: A Feature of Chronic Viral Hepatitis?
- What Is the Structure and Function of Hepatitis B?
- Can Biological Factors Like Hepatitis B Explain the Bulk of Gender Imbalance in China?
- What Is Chronically Infected Liver Hepatitis Virus?
- Acute-on-Chronic Liver Failure From Chronic-hepatitis-B, Who Is the Behind Scenes?
- What Is the Environmental Stability and Infectivity of Hepatitis C Virus In Various Human Body Fluids?
- How Do I Get Immunity to the Infectious Hepatitis Virus?
- What Is the Relationship Between HIV, Hepatitis, and Substance Abuse?
- What Is the Link Between Schistosomiasis and Hepatitis C?
- What Is the Research and Development in the EU Regarding the Treatment of Hepatitis C?
- Why Is Hepatitis the Most Serious Disease in the World in the 21st Century?
- What Are the Common Conditions Associated With Hepatitis C?
- What Is the Role and Purpose of Infection Control in Preventing the Spread of Hepatitis C?
- How Common Is Hepatitis in Homeless Veterans?